During the past decade, KEM Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 11 clinical trials were completed, i.e. on average, 55% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "KEM Hospital" #1 sponsor was "Gilead Sciences" with 6 trials, followed by "Karolinska Institutet" with 3 trials sponsored, "Seth Gordhandas Sunderdas Medical College" with 3 trials sponsored, "United Therapeutics" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "KEM Hospital" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "All India Institute of Medical Sciences, New Delhi" with 1 trials as a collaborator, "Asian Clinical Trials" with 1 trials as a collaborator, "Cardialysis BV" with 1 trials as a collaborator and "Ministry of Science and Technology, India" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "KEM Hospital" are "Pulmonary Arterial Hypertension" (3 trials), "Trauma" (3 trials), "Covid19" (2 trials), "Crohn's Disease" (2 trials) and "Dyslipidemia" (2 trials). Many other conditions were trialed in "KEM Hospital" in a lesser frequency.

Most popular intervention types in "KEM Hospital" are "Drug" (25 trials), "Biological" (6 trials), "Other" (5 trials), "Behavioral" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "TDF" (3 trials), "Filgotinib" (2 trials), "No intervention" (2 trials) and "Pitavastatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "KEM Hospital" are 40 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "KEM Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in KEM Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in KEM Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".